Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617.

Justin FerdinandusJohn VioletShahneen SandhuRodney J HicksAravind S Ravi KumarAmir IravaniGrace KongTim AkhurstSue Ping ThangDeclan G MurphyScott WilliamsMichael S Hofman

Published in: European journal of nuclear medicine and molecular imaging (2020)

In addition to established biomarkers, both FDG and PSMA PET/CT parameters have prognostic significance for survival in men undergoing LuPSMA therapy.

Keyphrases

pet ct
positron emission tomography
middle aged
squamous cell carcinoma
small cell lung cancer
stem cells
computed tomography
free survival
smoking cessation
replacement therapy